January 1, 2014Open Access

In vivoanti-tumor activity of the organometallic ruthenium(ii)-arene complex Ru(η6-p-cymene)Cl2(pta) (RAPTA-C) in human ovarian and colorectal carcinomas

Key points are not available for this paper at this time.

Based on the clinical success of platinum-based anti-cancer drugs, a variety of other metal-based anti-cancer compounds are being investigated.

KI fragen

Bookmark

View Full Paper

Cite This Study

Weiss et al. (Wed,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark

View Full Paper